1. Home
  2. RKDA vs MBIO Comparison

RKDA vs MBIO Comparison

Compare RKDA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$0.44

Market Cap

1.1M

Sector

Industrials

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.54

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
MBIO
Founded
2002
2015
Country
United States
United States
Employees
8
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
4.1M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
RKDA
MBIO
Price
$0.44
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.3K
24.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
66.92
98.99
EPS
N/A
N/A
Revenue
$4,858,000.00
N/A
Revenue This Year
$61.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.47
52 Week High
$6.71
$1.84

Technical Indicators

Market Signals
Indicator
RKDA
MBIO
Relative Strength Index (RSI) 39.75 N/A
Support Level $0.39 N/A
Resistance Level $0.55 N/A
Average True Range (ATR) 0.04 0.00
MACD 0.00 0.00
Stochastic Oscillator 28.56 0.00

Price Performance

Historical Comparison
RKDA
MBIO

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: